Evidence map›Paper›PMID 27582607›Full record

ReviewSeminars in interventional radiology2016

MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer.

David A Woodrum, Krzysztof R Gorny, Bernadette Greenwood, Lance A Mynderse

Abstract readReview
In one paragraph

Review in Seminars in interventional radiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. [MR-Guided Targeted Prostate Biopsy from Radiologists' Perspective].Journal of the Korean Society of Radiology · 2023
    Review
  3. Review
  4. All change in the prostate cancer diagnostic pathway.Nature reviews. Clinical oncology · 2020
    Review
  5. Article
  6. Review
  7. Article
  8. Enabling Technology for MRI-Guided Intervention.Topics in magnetic resonance imaging : TMRI · 2018
    Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David A WoodrumDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Krzysztof R GornyDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Bernadette GreenwoodDesert Medical Imaging, Indian Wells, California.
Lance A MynderseDepartment of Urology, Mayo Clinic, Rochester, Minnesota.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is the most commonly diagnosed noncutaneous cancer and second-leading cause of death in men. Many patients with clinically organ-confined prostate cancer undergo definitive, curative treatment of the whole gland with either radical prostatectomy or radiation therapy. However, many men are reluctant to take the definitive step due to potential morbidity associated with either therapy. A growing interest in active surveillance or focal therapy has emerged as realistic alternatives for many patients. With each of these management strategies, it is critical to accurately quantify and stage the cancer with improved biopsy targeting and more precise imaging with magnetic resonance imaging (MRI). Furthermore, having dependable prostate imaging allows for targeted biopsies to improve the yield of clinically significant prostate cancer and decrease detection of indolent prostate cancer. MRI-guided targeted biopsy techniques include cognitive MRI/transrectal ultrasound fusion biopsy, in-bore transrectal targeted biopsy using a calibrated guidance device, and in-bore direct MR-guided transperineal biopsy with a software-based transperineal grid template. Herein we present a contemporary review of MRI-guided targeted biopsy techniques for new and recurrent cancerous foci of the prostate.

Indexed as

interventional radiologyMRIMRI targeted biopsyneedle biopsyprostate cancer

Identifiers

PMID27582607
PMCPMC5005080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.